Empowering the future of cell therapy: leveraging partnerships to support advancement

Cell & Gene Therapy Insights 2023; 9(10), 1423–1433

DOI: 10.18609/cgti.2023.185

Published: 23 November 2023
Innovator Insight
J Patarroyo, F Mack, X de Mollerat du Jeu et al.

As the number of new cell therapy companies steadily rises, a different approach and perspective is needed to ensure correct support is provided to promote the success of new advancements and foster the therapeutic potential that early developers hold. The journey from discovery to market is challenging and collaborative relationships among stakeholders, such as drug developers, academic institutions, and industry partners, offer an effective framework for addressing these challenges. Tools providers specifically play a vital role by developing innovative technologies and platforms for cell therapy manufacturing. In this article, we will explore the significance of these relationships and discuss the related barriers, opportunities, and responsibilities for emerging drug developers, tool providers, and early discovery teams. We will share insights on how collaborative technical work can facilitate knowledge exchange, funding access, and impact the establishment of shared infrastructure, enabling efficient navigation of the complex cell therapy landscape. We will also share experiences relating to training, investment, and how collaborative frameworks can empower early discovery teams and create a thriving ecosystem that supports the advancement of cell therapy research and development.